Application of my research may help design selective clinical therapeutics to prevent multidrug...
Thesis topic: proteome analysis of multidrug-resistant breast cancer and leukaemia derived microparticles.
Supervisors: Associate Professor Mary Bebawy (School of Pharmacy, UTS), Professor Steven P. Djordjevic (Proteomics Core Facility, ithree Institute, UTS), Dr. Matthew P. Padula (Proteomics Core Facility, ithree Institute, UTS), Dr. Frederick Luk (School of Pharmacy, UTS)
I am currently pursuing my PhD at UTS, funded by an NHMRC grant to A/Prof Mary Bebawy. My research involves characterising microparticles to understand the differences in protein profile between those shed from resistant versus drug-sensitive cells. Microparticles are small membrane vesicles arising from membrane budding and are observed in most cell types during apoptosis or upon cell activation.
Application of my research may help design selective clinical therapeutics to prevent multidrug resistance.